Estrella Immunopharma, Inc. (ESLA)
About Estrella Immunopharma, Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$13.1M
- Total assets
- $3.2M
- Market cap
- $49.1M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $13.1M
- Operating income
- -$13.1M
- Income tax
- $838
- Net income
- -$13.1M
- EPS (basic)
- $-0.35
- EPS (diluted)
- $-0.35
Balance sheet
- Total assets
- $3.2M
- Current assets
- $1.7M
- Total liabilities
- $13.5M
- Current liabilities
- $13.5M
- Shareholders’ equity
- -$10.4M
Cash flow
- Operating cash flow
- -$1.8M
- Investing cash flow
- -$467.4K
- Financing cash flow
- $2.3M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $49.1M
- EPS (diluted)
- $-0.35
- Shares outstanding
- 62.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 2, 2023
Estrella Immunopharma, Inc. (ESLA) Stock Price
- Reported a net loss of $13.1M.
- Trading 74% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Estrella Immunopharma, Inc..
Write a review
News about Estrella Immunopharma, Inc.
News & sentiment via Polygon.io
Estrella Immunopharma, Inc.: frequently asked questions
Is Estrella Immunopharma, Inc. an American company?
Estrella Immunopharma, Inc. is a US-based company headquartered in Emeryville, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Estrella Immunopharma, Inc. headquartered?
Estrella Immunopharma, Inc. is headquartered in Emeryville, California, United States.
Is Estrella Immunopharma, Inc. publicly traded?
Yes — Estrella Immunopharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol ESLA on the NASDAQ.
What does Estrella Immunopharma, Inc. do?
Estrella Immunopharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
